Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT PHARMOVA vs DR. REDDYS LAB - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    JUBILANT PHARMOVA DR. REDDYS LAB JUBILANT PHARMOVA /
DR. REDDYS LAB
 
P/E (TTM) x -2,647.7 19.7 - View Chart
P/BV x 1.7 4.4 37.8% View Chart
Dividend Yield % 0.9 0.6 135.3%  

Financials

 JUBILANT PHARMOVA    DR. REDDYS LAB
EQUITY SHARE DATA
    JUBILANT PHARMOVA
Mar-23
DR. REDDYS LAB
Mar-23
JUBILANT PHARMOVA /
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs4964,656 10.6%   
Low Rs2693,788 7.1%   
Sales per share (Unadj.) Rs394.41,481.4 26.6%  
Earnings per share (Unadj.) Rs-4.1270.7 -1.5%  
Cash flow per share (Unadj.) Rs30.7345.7 8.9%  
Dividends per share (Unadj.) Rs5.0040.00 12.5%  
Avg Dividend yield %1.30.9 138.1%  
Book value per share (Unadj.) Rs338.61,389.6 24.4%  
Shares outstanding (eoy) m159.28166.53 95.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.02.8 34.0%   
Avg P/E ratio x-93.815.6 -601.5%  
P/CF ratio (eoy) x12.412.2 101.9%  
Price / Book Value ratio x1.13.0 37.2%  
Dividend payout %-122.714.8 -830.6%   
Avg Mkt Cap Rs m60,873703,039 8.7%   
No. of employees `000NANA-   
Total wages/salary Rs m21,66046,466 46.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m62,817246,697 25.5%  
Other income Rs m38310,555 3.6%   
Total revenues Rs m63,201257,252 24.6%   
Gross profit Rs m7,31763,860 11.5%  
Depreciation Rs m5,54012,502 44.3%   
Interest Rs m1,8821,428 131.8%   
Profit before tax Rs m27860,485 0.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m92715,412 6.0%   
Profit after tax Rs m-64945,073 -1.4%  
Gross profit margin %11.625.9 45.0%  
Effective tax rate %333.525.5 1,309.0%   
Net profit margin %-1.018.3 -5.7%  
BALANCE SHEET DATA
Current assets Rs m37,624203,161 18.5%   
Current liabilities Rs m17,72485,721 20.7%   
Net working cap to sales %31.747.6 66.5%  
Current ratio x2.12.4 89.6%  
Inventory Days Days2579 31.0%  
Debtors Days Days56107 52.1%  
Net fixed assets Rs m71,668112,638 63.6%   
Share capital Rs m159833 19.1%   
"Free" reserves Rs m53,772230,571 23.3%   
Net worth Rs m53,931231,404 23.3%   
Long term debt Rs m31,1041,278 2,433.8%   
Total assets Rs m109,292315,799 34.6%  
Interest coverage x1.143.4 2.6%   
Debt to equity ratio x0.60 10,442.7%  
Sales to assets ratio x0.60.8 73.6%   
Return on assets %1.114.7 7.7%  
Return on equity %-1.219.5 -6.2%  
Return on capital %2.526.6 9.5%  
Exports to sales %052.2 0.0%   
Imports to sales %4.116.8 24.3%   
Exports (fob) Rs mNA128,803 0.0%   
Imports (cif) Rs m2,56441,484 6.2%   
Fx inflow Rs m7,100128,803 5.5%   
Fx outflow Rs m2,56441,484 6.2%   
Net fx Rs m4,53687,319 5.2%   
CASH FLOW
From Operations Rs m6,60758,875 11.2%  
From Investments Rs m-5,444-41,373 13.2%  
From Financial Activity Rs m-1,567-26,861 5.8%  
Net Cashflow Rs m301-9,073 -3.3%  

Share Holding

Indian Promoters % 47.4 26.7 177.8%  
Foreign collaborators % 3.3 0.0 -  
Indian inst/Mut Fund % 23.2 47.3 49.0%  
FIIs % 20.3 28.6 70.9%  
ADR/GDR % 0.0 15.3 -  
Free float % 49.3 58.0 85.0%  
Shareholders   86,588 257,794 33.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare JUBILANT PHARMOVA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    ZYDUS LIFESCIENCES    MANKIND PHARMA    


More on Jubilant Pharmova vs Dr. Reddys

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Jubilant Pharmova vs Dr. Reddys Share Price Performance

Period Jubilant Pharmova Dr. Reddys S&P BSE HEALTHCARE
1-Day -0.54% 1.78% 1.18%
1-Month 2.20% -4.23% -0.75%
1-Year 109.28% 35.93% 61.82%
3-Year CAGR -6.79% 10.85% 18.16%
5-Year CAGR -2.78% 17.77% 19.79%

* Compound Annual Growth Rate

Here are more details on the Jubilant Pharmova share price and the Dr. Reddys share price.

Moving on to shareholding structures...

The promoters of Jubilant Pharmova hold a 50.7% stake in the company. In case of Dr. Reddys the stake stands at 26.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Jubilant Pharmova and the shareholding pattern of Dr. Reddys.

Finally, a word on dividends...

In the most recent financial year, Jubilant Pharmova paid a dividend of Rs 5.0 per share. This amounted to a Dividend Payout ratio of -122.7%.

Dr. Reddys paid Rs 40.0, and its dividend payout ratio stood at 14.8%.

You may visit here to review the dividend history of Jubilant Pharmova, and the dividend history of Dr. Reddys.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.